How have HLN shares performed this year?

Haleon's stock was trading at $8.23 at the beginning of 2024. Since then, HLN stock has increased by 23.7% and is now trading at $10.18. View the best growth stocks for 2024 here .

How were Haleon's earnings last quarter?

Haleon plc (NYSE:HLN) announced its quarterly earnings results on Thursday, August, 1st. The company reported $0.08 EPS for the quarter, missing analysts' consensus estimates of $0.09 by $0.01. The firm had revenue of $3.50 billion for the quarter, compared to analysts' expectations of $3.55 billion. Haleon had a trailing twelve-month return on equity of 13.15% and a net margin of 9.71%.

Who are Haleon's major shareholders?

Top institutional investors of Haleon include Clearbridge Investments LLC (0.91%), Sculptor Capital LP (0.19%), Douglas Lane & Associates LLC (0.19%) and Envestnet Asset Management Inc. (0.17%).

How do I buy shares of Haleon?

Shares of HLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSE:HLN

Haleon (HLN) Stock Price, News & Analysis

$10.18

+0.09 (+0.89%)

(As of 08/30/2024 08:54 PM ET)

Compare

Today's Range: $10.10
▼
$10.23
50-Day Range: $8.27
▼
$10.18
52-Week Range: $7.70
▼
$10.23

Volume: 3.16 million shs
Average Volume: 5.05 million shs
Market Capitalization: $46.48 billion

P/E Ratio: 33.93
Dividend Yield: 0.98%
Price Target: N/A

Get Haleon alerts:

Haleon MarketRank™ Stock Analysis

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
0.31% of Float Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.87
Based on 10 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 10.87%
From $0.46 to $0.51 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.51 out of 5 stars

Medical Sector

279th out of 928 stocks

Toilet Preparations Industry

6th out of 12 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Haleon.
Read more about Haleon's stock forecast and price target.

5.0

Short Interest

Percentage of Shares Shorted
0.31% of the float of Haleon has been sold short.
Short Interest Ratio / Days to Cover
Haleon has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Haleon has recently decreased by 9.60%, indicating that investor sentiment is improving significantly.

2.5

Dividend Strength

Dividend Yield
Haleon pays a meaningful dividend of 1.02%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Haleon does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Haleon is 33.33%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Haleon will have a dividend payout ratio of 19.61% next year. This indicates that Haleon will be able to sustain or increase its dividend.
Read more about Haleon's dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for HLN.

3.3

News and Social Media Coverage

News Sentiment
Haleon has a news sentiment score of 0.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 10 news articles for Haleon this week, compared to 3 articles on an average week.
Search Interest
14 people have searched for HLN on MarketBeat in the last 30 days. This is an increase of 56% compared to the previous 30 days.
MarketBeat Follows
3 people have added Haleon to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Haleon insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 6.67% of the stock of Haleon is held by institutions.
Read more about Haleon's insider trading history.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Haleon are expected to grow by 10.87% in the coming year, from $0.46 to $0.51 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Haleon is 33.93, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 123.31.
Price to Earnings Ratio vs. Sector
The P/E ratio of Haleon is 33.93, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 99.94.
Price to Earnings Growth Ratio
Haleon has a PEG Ratio of 2.99. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Haleon has a P/B Ratio of 2.20. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.
Read more about Haleon's valuation and earnings.

See Top Rated MarketRank™ Stocks Here

Ad Paradigm Press

DNC crowns Kamala, but she’s already DONE

In Trump’s hands, I believe this superweapon could restore America’s global dominance. It will also help Americans struggling under Bidenomics by potentially sending 5 military stocks SOARING. Historically, similar stocks have shot up 16,270% in just 18 months.

Full details are included in this announcement.

About Haleon Stock (NYSE:HLN)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

HLN Stock Price History

30 days | 90 days | 365 days | Advanced Chart

HLN Stock News Headlines

August 29, 2024 | msn.com

Haleon plc (HLN): A Cheap Pharmaceutical Stock to Buy According to Short Sellers

August 28, 2024 | sg.finance.yahoo.com

Haleon plc (HLNL.XC)

September 2, 2024 | Monument Traders Alliance (Ad)

FREE Daily Profits Live Open House

Over the past year, members of Millionaire trader Nate Bear's Daily Profits Live chatroom have had 62 opportunities to DOUBLE their money... Now it's YOUR CHANCE to hunt MASSIVE gains like these with a professional trader for an ENTIRE WEEK... 100% FREE!

August 26, 2024 | seekingalpha.com

Lanny's Stock Sales Through June 30, 2024

August 6, 2024 | markets.businessinsider.com

Haleon PLC: Solid Performance Balanced with Premium Valuation Leads to Neutral Rating

August 2, 2024 | seekingalpha.com

Haleon plc 2024 Q2 - Results - Earnings Call Presentation

August 1, 2024 | uk.finance.yahoo.com

Haleon’s share price leaps 3% as first-half results reveal 11% profit increase. Is it time I buy?

August 1, 2024 | reuters.com

Haleon sees high single-digit growth for annual organic operating profit

September 2, 2024 | Monument Traders Alliance (Ad)

FREE Daily Profits Live Open House

July 19, 2024 | markets.businessinsider.com

Barclays Keeps Their Buy Rating on Haleon PLC (HLN)

June 26, 2024 | reuters.com

Haleon to sell nicotine replacement therapy business outside US for $633 mln

June 3, 2024 | prnewswire.com

Yellow Wood Partners Portfolio Company Suave Brands Company Completes ChapStick Acquisition

May 17, 2024 | benzinga.com

GSK Completely Exits Sensodyne Toothpaste Maker Haleon In $1.6B Sale

May 17, 2024 | reuters.com

GSK raises $1.5 bln from offloading Haleon stake at a discount

May 16, 2024 | reuters.com

GSK intends to sell its remaining stake in Haleon

May 7, 2024 | seekingalpha.com

Haleon: Pressures Are Temporary, But Closer To Fair Value

May 2, 2024 | msn.com

Sensodyne-maker Haleon posts tepid sales as demand for some products cools off

May 2, 2024 | seekingalpha.com

Sales Call

See More Headlines

Receive HLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/01/2024
Ex-Dividend for 9/19 Dividend: 8/16/2024
Today: 9/01/2024
Dividend Payable: 9/19/2024
Next Earnings (Estimated): 11/07/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Toilet preparations
Sub-Industry: Consumer Goods
Current Symbol: NYSE:HLN
CUSIP: N/A
CIK: 1900304
Web: www.haleon.com
Phone: 44-19-3282-2000
Fax: N/A
Employees: 25,408
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $0.30
Trailing P/E Ratio: 33.93
Forward P/E Ratio: 22.13
P/E Growth: 2.99
Net Income: $1.30 billion
Net Margins: 9.71%
Pretax Margin: 14.40%
Return on Equity: 13.15%
Return on Assets: 6.52%

Debt

Debt-to-Equity Ratio: 0.44
Current Ratio: 0.84
Quick Ratio: 0.58

Sales & Book Value

Annual Sales: $11.26 billion
Price / Sales: 4.13
Cash Flow: $0.37 per share
Price / Cash Flow: 27.83
Book Value: $4.62 per share
Price / Book: 2.20

Miscellaneous

Outstanding Shares: 4,566,151,000
Free Float: N/A
Market Cap: $46.48 billion
Optionable: Not Optionable
Beta: 0.24

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. Brian James McNamara (Age 58)
CEO & Executive Director
Comp: $4.32M
Mr. Tobias Hannes Hestler (Age 52)
CFO & Executive Director
Comp: $2.4M
Ms. Sonya Ghobrial (Age 50)
Head of Investor Relations
Ms. Tamara Rogers (Age 54)
Chief Marketing Officer
Mr. Filippo Lanzi
President of EMEA & LatAm
Mr. Keith Choy (Age 55)
President of Asia Pacific
Ms. Lisa Paley (Age 57)
President of North America
Mr. Franck Riot (Age 56)
Chief R&D Officer
Mr. Bjorn Timelin
Head of Strategy
Ms. Namrata P. Patel (Age 58)
Chief Supply Chain Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

Should I Buy Haleon Stock? HLN Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Haleon plc:

Haleon plc has shown consistent growth in its stock price, currently trading at $9.81 per share, with a market capitalization of $44.79 billion.
The company has a diverse product portfolio in consumer healthcare products, operating across multiple regions globally, which provides a strong revenue base.
Institutional investors, such as Clearbridge Investments LLC and Wellington Management Group LLP, have significantly increased their positions in Haleon plc, indicating confidence in the company's future prospects.
Analysts have given Haleon plc a "Moderate Buy" consensus rating, with several recommending a "buy" rating, suggesting positive sentiment towards the stock.
Haleon plc is forecasted to post earnings per share of 0.47 for the current fiscal year, indicating potential profitability and financial stability.

Cons

Investors should be bearish about investing in Haleon plc for these reasons:

Despite the positive analyst ratings, there is a risk associated with the stock as one analyst has rated it as a "hold," which may indicate some uncertainty in the market.
The recent dividend cut by Haleon plc may raise concerns among investors who rely on dividend income as part of their investment strategy.
The company's debt-to-equity ratio of 0.53 may be a cause for caution, as higher debt levels can impact financial stability and future growth potential.
While the stock has shown some growth, the price-to-earnings ratio of 32.70 and price-to-earnings-growth ratio of 2.69 may suggest that the stock is currently trading at a premium valuation.
Investors should consider market volatility and economic conditions when evaluating investments in Haleon plc, as external factors can influence stock performance.

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, August 26, 2024. Please send any questions or comments about these Haleon pros and cons to [email protected].

HLN Stock Analysis - Frequently Asked Questions

How have HLN shares performed this year?: Haleon's stock was trading at $8.23 at the beginning of 2024. Since then, HLN stock has increased by 23.7% and is now trading at $10.18.
View the best growth stocks for 2024 here.
How were Haleon's earnings last quarter?: Haleon plc (NYSE:HLN) announced its quarterly earnings results on Thursday, August, 1st. The company reported $0.08 EPS for the quarter, missing analysts' consensus estimates of $0.09 by $0.01. The firm had revenue of $3.50 billion for the quarter, compared to analysts' expectations of $3.55 billion. Haleon had a trailing twelve-month return on equity of 13.15% and a net margin of 9.71%.
Who are Haleon's major shareholders?: Top institutional investors of Haleon include Clearbridge Investments LLC (0.91%), Sculptor Capital LP (0.19%), Douglas Lane & Associates LLC (0.19%) and Envestnet Asset Management Inc. (0.17%).
How do I buy shares of Haleon?: Shares of HLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:HLN) was last updated on 9/2/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

Haleon (HLN) Stock Price, News & Analysis

Haleon MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Consensus Rating

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Dividend Yield

Dividend Growth

Dividend Coverage

Dividend Sustainability

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Insider Buying vs. Insider Selling

Percentage Held by Institutions

Earnings and Valuation

Earnings Growth

Price to Earnings Ratio vs. the Market

Price to Earnings Ratio vs. Sector

Price to Earnings Growth Ratio

Price to Book Value per Share Ratio